Cancer Research

The integration of near-infrared light with gold nanoparticles allows clinicians to thermally destroy cancer cells from the inside out without harming surrounding tissue. This technological breakthrough addresses a critical need in oncology, as colon cancer currently maintains its position as one

Baseline next-generation sequencing reveals that over 76 percent of lung cancer patients harbor additional genomic alterations that can shorten treatment durability. This statistic underscores the persistent challenge of managing advanced malignancies outside the sterile confines of traditional

Latent Profile Analysis has identified a specific demographic of cancer survivors who log over thirteen hours of stillness, posing a major challenge for long-term health. The transition from active cancer treatment to recovery is a pivotal moment in a patient's life, often referred to by clinicians

The shift by Cellectis to prioritize APOC3 and PCSK9 programs illustrates a broader movement toward genomic modulation for long-lasting treatment of chronic illnesses. This strategic pivot marks a departure from the industry’s early fixation on ultra-rare genetic disorders, signaling a newfound

Advanced laser nanofabrication techniques now enable the production of SERS substrates with nanoparticle gaps precisely controlled by chemical reduction times. This technological leap addresses one of the most persistent bottlenecks in modern precision biomedicine, where the ability to isolate

The biological quest for longevity has shifted from merely repairing "broken parts" to understanding the sophisticated software governing cellular life. Recent breakthroughs, highlighted by the "Guardian Paradox" framework, suggest that aging is not just an accumulation of damage, but a result of